Turkish researchers produce therapeutic protein from transgenic rats

Dunya - Turkish researchers have succeeded in producing a protein which prevents the uncontrolled division of cells (cancer) in milk of transgenic rats. The interferon (IFN) gamma protein promises to be a breakthrough in treating diseases such as cancer, hepatitis and viral infections. The research project at the Turkish Scientific Technical Research Organization (TUBITAK) was considered the second of its kind in the world, and will allow researchers to produce the IFN gamma protein more abundantly and cheaply. "The development of genetic engineering techniques, known as recombinant DNA technology, has allowed scientists to produce genetically modified organisms or transgenic organisms by collecting DNA molecules from various sources and combining them into one molecule to create a new set of genes", said Haydar Bagis from TUBITAK's Marmara Research Center (MAM) - Institute for Genetic Engineering and Biotechnology. Bagis stated, "The use of transgenic organisms has added momentum to research in biology, pharmaceutics and veterinary. We call those organisms ‘bioreactors’. During our work, we developed a new kind of transgenic rats which are resistant to freezing."